Varian led a round for the targeted cancer drug developer that included existing investors such as Facit and Johnson & Johnson.

NUI Maynooth spinout Avectas has added capital to converted equity previously supplied by therapeutics developer Adapt Pharma among others.

UVA’s seed fund and corporate venturing unit PharmStandard Ventures featured in topical dry eye syndrome peptide spinout TearSolutions' financing round, taking its total to $21.5m.

SoftBank has tapped three executives to help run its $5bn Latin America-focused fund, with Paulo Passoni and Shu Nyatta to work alongside managing partner André Maciel.

The cosmetic surgery booking and reviews platform, which counts Tencent among its investors, has filed to go public in the US.

Lundbeckfonden Ventures-backed Trevi has filed for an $86.2m IPO to fund clinical trials for pruritus-focused drug treatments.

NovaUCD-based patient lingerie manufacturer Theya Healthcare has been backed by investors including Enterprise Ireland as it prepares for expansion in the US.

The insurance provider has teamed with the city of Wuhan to form a healthcare fund sized at approximately $3bn, with LPs including WeDoctor and Jointown Pharmaceutical.

Varian Medical Systems led University of Michigan's robotic-assisted ultrasound device spinout's series C round, which also included Johnson & Johnson Innovation - JJDC.

Nationwide Children’s-founded advanced pathology platform Deep Lens has now raised $17.5m in all as it looks to grow its business in the clinical trial recruitment segment.